Dikmen Z.G., Gellert G.C., Dogan P., Yoon H., Lee Y.B., Wright W.E., Shay J.W. Bioluminescence Imaging to Test the Anticancer Effects of a HIF-1alpha Inhibitor, RX0047. 2006. Submitted.
Richer E., Slavine N., Lewis M.A., Tsyganov Z., Shay J.W., Gellert G.C., Dikmen Z.G., Mason R.P., Antich P.P. Light Emission Tomography (LET): Visualizing Small Animal Biology in Three-Dimensions. 2006. Nature Biotechnology. Re-submitted, final revisions.
Gellert G.C., Jackson S.R., Dikmen Z.G., Wright W.E., Shay J.W. Telomerase as a Therapeutic Target in Cancer. 2005. Drug Discovery Today: Disease Mechanisms. 2 (2): 159-164.
Gellert G.C., Dikmen Z.G., Wright W.E., Gryaznov S., Shay J.W. Effects of a Novel Telomerase Inhibitor, GRN163L, in Human Breast Cancer. 2005. Breast Cancer Research and Treatment. 96 (1): 73-81.
Dikmen Z.G., Gellert G.C., Jackson S., Gryaznov S., Tressler R., Dogan P., Wright W.E., Shay J.W. Effects of GRN163L, a Novel Telomerase Inhibitor, on Human Lung Cancer (A549-Luc) Cells. 2005. Cancer Research. 65 (17): 7866-73.
Herbert B.-S., Gellert G.C., Hochreiter A., Pongracz K., Wright W.E., Zielinska D., Chin A.C., Harley C., Shay J.W., Gryaznov S.M. Lipid Modification of GRN163, an N3’→P5’ – thio-Phosphoramidate Oligonucleotide, Enhances the Potency of Telomerase Inhibition. 2005. Oncogene. 24 (33): 5262-8.
Dikmen Z.G., Gellert G., Dogan P., Mason R., Antich P., Richer E., Wright W.E., Shay J.W. A New Diagnostic System in Cancer Research: Bioluminescent Imaging (BLI). 2004. Turkish Journal of Medical Science. 35: 65-70.
Gellert G.C., Goldfarb R.H., Kitson R.P. Physical Association of uPAR with the aV Integrin on the Surface of Human NK Cells. 2003. Biochemical and Biophysical Research Communications. 315 (4): 1025-1032.
Gellert G.C., Kitson R.P., Goldfarb R.H. Urokinase-type Plasminogen Acitvator Receptor Crosslinking in an NK Cell Line Increases Integrin Expression by the MAP Kinase/ERK 1/2 Signaling Pathway. 2003. Journal of Cellular Biochemistry. 82 (2): 279-288.
Gellert G.C., Kitson R.P., Goldfarb R.H. Modulation of NK Cell Integrins by Urokinase Plasminogen Activator Receptor (uPAR). 2002. FASEB J. 16: A1212.
|
